NPKI Insider: CEO Exercises $4.32 Options, Sells at $10.34 Avg
Rhea-AI Filing Summary
Matthew Lanigan, President & CEO and a director of NPK International Inc. (NPKI), exercised 68,896 non-qualified stock options with a $4.32 exercise price and immediately sold those 68,896 shares in the open market on 08/22/2025 pursuant to a Rule 10b5-1 trading plan adopted May 23, 2025. The shares were sold at a weighted average price of $10.3422, with individual sale prices ranging from $9.97 to $10.42. Following the transactions, Lanigan’s reported beneficial ownership fell from 1,164,809 shares to 1,095,913 shares. The filer offers to provide a detailed breakdown of the number of shares sold at each price upon request.
Positive
- Transactions were executed pursuant to a documented Rule 10b5-1 trading plan adopted May 23, 2025
- Filer commits to provide a detailed breakdown of the number of shares sold at each price within the disclosed range, improving transparency
- Report discloses exercise price ($4.32), weighted average sale price ($10.3422), and the range $9.97–$10.42
Negative
- Reporting person sold 68,896 shares in open-market transactions, reducing beneficial ownership from 1,164,809 to 1,095,913
- Insider sale occurred despite the reporting person’s role as President & CEO and director, which may be viewed negatively by some investors seeking insider accumulation
Insights
TL;DR: CEO exercised options and sold the resulting 68,896 shares under a pre-established 10b5-1 plan; ownership decreased by 68,896 shares.
The filing shows a routine insider exercise and concurrent open-market sale executed under a documented Rule 10b5-1 plan adopted May 23, 2025. The exercise price of the options was $4.32 and the weighted average sale price was $10.3422, producing a clear spread between exercise and sale prices. The disclosure includes an undertaking to provide per-price sale details, improving transparency. This transaction does not by itself reveal operational or financial performance changes beyond insider liquidity.
TL;DR: Insider sales were processed under a 10b5-1 plan, indicating pre-planned disposals and adherence to insider-trading controls.
The report identifies the reporting person as both President & CEO and a director, and confirms the trades were made pursuant to a 10b5-1 plan, which mitigates concerns about opportunistic timing. The form discloses exercise and sale details, the options’ original grant/exercise timeline, and the post-transaction share counts, which supports robust disclosure practices for insiders.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (right to buy) | 68,896 | $10.3422 | $713K |
| Exercise | Common Stock | 68,896 | $4.32 | $298K |
| Sale | Common Stock | 68,896 | $10.3422 | $713K |
Footnotes (1)
- The reported sale of 68,896 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 23, 2025. The price reported is the weighted average price. These shares were sold in multiple transactions in the open market at prices ranging from $9.97 to $10.42, inclusive. The reporting person undertakes to provide to NPK International Inc., any security holder of NPK International Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.